Shanxi Zhendong Pharmaceutical (300158) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.055x

Based on the latest financial reports, Shanxi Zhendong Pharmaceutical (300158) has a cash flow conversion efficiency ratio of -0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-197.94 Million ≈ $-28.96 Million USD) by net assets (CN¥3.63 Billion ≈ $530.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanxi Zhendong Pharmaceutical (300158) balance sheet quality index to measure how much of total assets are equity-financed.

Shanxi Zhendong Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Shanxi Zhendong Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Shanxi Zhendong Pharmaceutical to evaluate the quality of earnings relative to operating cash generation.

Shanxi Zhendong Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanxi Zhendong Pharmaceutical ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Red Violet Inc
NASDAQ:RDVT
0.100x
Karnov Group AB
ST:KAR
0.108x
Slate Grocery REIT
TO:SGR-UN
0.019x
Finnair Oyj
HE:FIA1S
0.160x
Shenzhen Topway Video Communication Co Ltd
SHE:002238
0.018x
Zhejiang Dehong Automotive
SHG:603701
-0.014x
Luyin Investment Group Co Ltd
SHG:600784
-0.007x
Shenzhen Comix Group Co Ltd
SHE:002301
0.017x

Annual Cash Flow Conversion Efficiency for Shanxi Zhendong Pharmaceutical (2007–2024)

The table below shows the annual cash flow conversion efficiency of Shanxi Zhendong Pharmaceutical from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300158 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.66 Billion
≈ $535.61 Million
CN¥-149.82 Million
≈ $-21.92 Million
-0.041x -10.85%
2023-12-31 CN¥5.14 Billion
≈ $752.74 Million
CN¥-189.95 Million
≈ $-27.80 Million
-0.037x -323.47%
2022-12-31 CN¥5.22 Billion
≈ $764.33 Million
CN¥86.31 Million
≈ $12.63 Million
0.017x -53.21%
2021-12-31 CN¥8.05 Billion
≈ $1.18 Billion
CN¥284.45 Million
≈ $41.62 Million
0.035x -10.36%
2020-12-31 CN¥5.63 Billion
≈ $824.31 Million
CN¥221.94 Million
≈ $32.48 Million
0.039x +15.04%
2019-12-31 CN¥5.44 Billion
≈ $796.21 Million
CN¥186.35 Million
≈ $27.27 Million
0.034x +18.89%
2018-12-31 CN¥5.36 Billion
≈ $784.69 Million
CN¥154.48 Million
≈ $22.60 Million
0.029x +255.11%
2017-12-31 CN¥5.56 Billion
≈ $813.28 Million
CN¥45.09 Million
≈ $6.60 Million
0.008x +195.63%
2016-12-31 CN¥5.27 Billion
≈ $771.41 Million
CN¥-44.72 Million
≈ $-6.54 Million
-0.008x -111.34%
2015-12-31 CN¥2.03 Billion
≈ $297.12 Million
CN¥151.84 Million
≈ $22.22 Million
0.075x +101.19%
2014-12-31 CN¥1.97 Billion
≈ $288.29 Million
CN¥73.23 Million
≈ $10.72 Million
0.037x +197.00%
2013-12-31 CN¥1.96 Billion
≈ $286.56 Million
CN¥-75.04 Million
≈ $-10.98 Million
-0.038x -138.43%
2012-12-31 CN¥1.90 Billion
≈ $277.96 Million
CN¥189.40 Million
≈ $27.72 Million
0.100x +308.83%
2011-12-31 CN¥1.86 Billion
≈ $271.95 Million
CN¥-88.73 Million
≈ $-12.98 Million
-0.048x -362.53%
2010-12-31 CN¥1.78 Billion
≈ $260.67 Million
CN¥32.40 Million
≈ $4.74 Million
0.018x -84.54%
2009-12-31 CN¥359.31 Million
≈ $52.58 Million
CN¥42.28 Million
≈ $6.19 Million
0.118x -5.43%
2008-12-31 CN¥266.72 Million
≈ $39.03 Million
CN¥33.18 Million
≈ $4.86 Million
0.124x -82.94%
2007-12-31 CN¥176.42 Million
≈ $25.82 Million
CN¥128.65 Million
≈ $18.82 Million
0.729x --

About Shanxi Zhendong Pharmaceutical

SHE:300158 China Drug Manufacturers - Specialty & Generic
Market Cap
$731.83 Million
CN¥5.00 Billion CNY
Market Cap Rank
#10245 Global
#2691 in China
Share Price
CN¥5.04
Change (1 day)
+1.41%
52-Week Range
CN¥4.57 - CN¥9.45
All Time High
CN¥12.00
About

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is b… Read more